NiKang Therapeutics has signed a new collaboration agreement with the Swiss pharmaceutical giant Roche to study a deadly liver cancer.
The portfolio companies of The Innovation Space recently eclipsed $1 billion in funding as the not-for-profit prepares for new tenants.
WILMINGTON – The private biopharmaceutical startup NiKang Therapeutics announced Tuesday that it has signed a licensing agreement for one of its small-molecule therapy drugs in China, marking its second such […]
WILMINGTON – The biopharmaceutical startup NiKang Therapeutics announced Wednesday that it has signed a second clinical trial collaboration with a biopharma firm for its small-molecule therapy drug in about a […]
WILMINGTON – The greater Wilmington area is attracting a burgeoning growth of life science firms, many of which are investigating potential cancer treatments. Incyte Corp. and Prelude Therapeutics are among […]
Premier Digital Partners
© 2024 Delaware Business Times
